Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Grissom Exits Boston Scientific Beltway; Polymer Traffic To Continue

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific VP-Federal Affairs, Reimbursement & Outcomes Planning Randel Richner will direct Washington, D.C. operations on a temporary basis, now that Tom Grissom has left the firm

You may also be interested in...

DRG Split For Complex DES May Herald Multi-Vessel Payment Reforms

CMS remains open to considering whether inpatient diagnosis-related groups (DRGs) for drug-eluting stents should reflect differences in the number of stents implanted and/or vessels treated

CMS Issues “Coverage With Evidence Development” Draft Guidance

CMS' "coverage with evidence development" (CED) draft guidance appears to venture into FDA's traditional jurisdiction of evaluating safety and effectiveness

AdvaMed’s Bailey Gets Makeover As Cosmetic Head; Swift Search Anticipated

AdvaMed member companies who are not represented on the group's executive search committee are circulating a list of potential replacements for President Pam Bailey

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts